|
|
Volumn 19, Issue 8, 2007, Pages 588-590
|
|
Scottish Intercollegiate Guidelines Network (SIGN) 84 - National Clinical Guideline for the Management of Breast Cancer in Women1
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AROMATASE INHIBITOR;
BISPHOSPHONIC ACID DERIVATIVE;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
TAMOXIFEN;
TRASTUZUMAB;
ADJUVANT THERAPY;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CLINICAL PRACTICE;
CONSULTATION;
DRUG EFFICACY;
EDITORIAL;
HEALTH CARE ORGANIZATION;
HEALTH ECONOMICS;
HUMAN;
MASTECTOMY;
MEDICAL EXPERT;
PATIENT REFERRAL;
PEER REVIEW;
POSTMENOPAUSE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROCESS DEVELOPMENT;
RADIATION HAZARD;
RISK BENEFIT ANALYSIS;
SENTINEL LYMPH NODE BIOPSY;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
EVIDENCE-BASED MEDICINE;
FEMALE;
HUMANS;
INFORMATION SERVICES;
PRACTICE GUIDELINES AS TOPIC;
SCOTLAND;
|
|
EID: 34548152078
PISSN: 09366555
EISSN: None
Source Type: Journal
DOI: 10.1016/j.clon.2007.06.006 Document Type: Editorial |
|
Times cited : (13)
|
|
References (0)
|
